Page 133 - Informatorium Obat COVID-19 di Indonesia

Diakses 19 Maret 2020).
45. Cai J, Xu J, Lin D, et al A Case Series of Children with 2019
n-Corona Infection : Clinical and Epidemiological Features,
Clin Infect Dis,2020.
46. Liu W, Zhang Q, Chen J, et al Detection of COVID-19 in
Children in Early January 2020 in Wuhan, China. N.England
J Med, 2020.
47. Smith, T., Bushek, J., dan Prosser, T. 2020. COVID-19 Drug
Therapy – Potential Options. Clinical Drug Information –
Clinical Solutions. Diakses 28 Maret 2020.
48. https://www.idf.org/our-network/regions-
members/europe/europe-news/196-information-on-
corona-virus-disease-2019-COVID-19-outbreak-and-
guidance-for-people-with-diabetes.html, Diakses pada 31
Maret 2020.
49. European Medicines Agency (27 Maret 2020): EMA advises
continued use of medicines for hypertension, heart or
kidney diseases during COVID-19 pandemic.
https://www.ema.europe.eu/en/news/ema-advises-
continued-use-medicines-hypertension-heart-kidney-
diseases-during-covid-19-pandemic
50. UK Medicine and Healthcare products Rgulatory Agency (27
Maret 2020) Coronavirus (COVID-19) and high blood
pressure medication.
https://www.gov.uk./government/news/coronavirus
-covid-19-and-high-blood-pressure-medication
51. American College of Cardiology (17 Maret 2020).
HFSA/ACC/AHA Statement Addesses Concerns Re : Using
RAAS Antagonists in COVID-19
https://www.acc.org/latest-in-
cardiology/articles/2020/03/17/08/59hfsa-acc-aha-
statement-addresses-concerns-re-using raas-
antagonists-incovid-19
52. WHO Technical Report, Medication Safety in Polypharmacy,
WHO/UHC/SDS/2019.11. Diakses pada 31 Maret 2020
53. https://www.ema.europa.eu/en/documents/scientific-
guideline/guideline-investigation-drug-interactions-

124